NCT04486794View on ClinicalTrials.gov

Restylane® for the Treatment of Tear Trough Deformity

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 7, 2019

Primary Completion Date

December 30, 2020

Study Completion Date

December 31, 2020

Conditions
Tear Trough Eyelid Deformity
Interventions
DEVICE

Restylane®

Hyaluronic acid

Trial Locations (1)

H3R 3A1

Erevna Innovations Inc, Montreal

Sponsors
All Listed Sponsors
lead

Erevna Innovations Inc.

OTHER

NCT04486794 - Restylane® for the Treatment of Tear Trough Deformity | Biotech Hunter | Biotech Hunter